Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy

Hepatocellular carcinoma (HCC) is the third most frequent cause of tumor-related mortality and there are an estimated approximately 850,000 new cases annually. Most HCC patients are diagnosed at middle or advanced stage, losing the opportunity of surgery. The development of HCC is promoted by accumu...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Ding, Xiao-Xiao, Zhu, Qing-Ge, Zhang, Shi-Ming, Guan, Lei, Li, Ting, Zhang, Lei, Wang, Shi-Yang, Ren, Wan-Li, Chen, Xue-Mei, Zhao, Jing, Lin, Song, Liu, Zhi-Zhen, Bai, Yan-Xia, He, Bing, Zhang, Hu-Qin
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2017
主題:
Review
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589693/
https://ncbi.nlm.nih.gov/pubmed/28903454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18382
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍